These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 29082571)

  • 1. The role of peripheral vasopressin 1A and oxytocin receptors on the subcutaneous vasopressin antinociceptive effects.
    Manzano-García A; González-Hernández A; Tello-García IA; Martínez-Lorenzana G; Condés-Lara M
    Eur J Pain; 2018 Mar; 22(3):511-526. PubMed ID: 29082571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxytocin inhibits the rat medullary dorsal horn Sp5c/C1 nociceptive transmission through OT but not V
    García-Boll E; Martínez-Lorenzana G; Condés-Lara M; González-Hernández A
    Neuropharmacology; 2018 Feb; 129():109-117. PubMed ID: 29169960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body temperature and cardiac changes induced by peripherally administered oxytocin, vasopressin and the non-peptide oxytocin receptor agonist WAY 267,464: a biotelemetry study in rats.
    Hicks C; Ramos L; Reekie T; Misagh GH; Narlawar R; Kassiou M; McGregor IS
    Br J Pharmacol; 2014 Jun; 171(11):2868-87. PubMed ID: 24641248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurohormonal effects of oxytocin and vasopressin receptor agonists on spinal pain processing in male rats.
    Juif PE; Poisbeau P
    Pain; 2013 Aug; 154(8):1449-56. PubMed ID: 23707282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective and non-selective OT receptor agonists induce different locomotor behaviors in male rats via central OT receptors and peripheral V1a receptors.
    Wolfe M; Wisniewska H; Tariga H; Ibanez G; Collins JC; Wisniewski K; Qi S; Srinivasan K; Hargrove D; Lindstrom BF
    Neuropeptides; 2018 Aug; 70():64-75. PubMed ID: 29807652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal vasopressin alleviates formalin-induced nociception by enhancing GABAA receptor function in mice.
    Peng F; Qu ZW; Qiu CY; Liao M; Hu WP
    Neurosci Lett; 2015 Apr; 593():61-5. PubMed ID: 25782631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute prosocial effects of oxytocin and vasopressin when given alone or in combination with 3,4-methylenedioxymethamphetamine in rats: involvement of the V1A receptor.
    Ramos L; Hicks C; Kevin R; Caminer A; Narlawar R; Kassiou M; McGregor IS
    Neuropsychopharmacology; 2013 Oct; 38(11):2249-59. PubMed ID: 23676791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDMA ('Ecstasy'), oxytocin and vasopressin modulate social preference in rats: A role for handling and oxytocin receptors.
    Ramos L; Hicks C; Caminer A; Couto K; Narlawar R; Kassiou M; McGregor IS
    Pharmacol Biochem Behav; 2016; 150-151():115-123. PubMed ID: 27725273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a single administration of oxytocin or vasopressin and their interactions with two selective receptor antagonists on memory storage in mice.
    Boccia MM; Kopf SR; Baratti CM
    Neurobiol Learn Mem; 1998 Mar; 69(2):136-46. PubMed ID: 9619993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.
    Manning M; Stoev S; Chini B; Durroux T; Mouillac B; Guillon G
    Prog Brain Res; 2008; 170():473-512. PubMed ID: 18655903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxytocin inhibits the activity of acid-sensing ion channels through the vasopressin, V1A receptor in primary sensory neurons.
    Qiu F; Qiu CY; Cai H; Liu TT; Qu ZW; Yang Z; Li JD; Zhou QY; Hu WP
    Br J Pharmacol; 2014 Jun; 171(12):3065-76. PubMed ID: 24641084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WAY 267,464, a non-peptide oxytocin receptor agonist, impairs social recognition memory in rats through a vasopressin 1A receptor antagonist action.
    Hicks C; Ramos L; Reekie TA; Narlawar R; Kassiou M; McGregor IS
    Psychopharmacology (Berl); 2015 Aug; 232(15):2659-67. PubMed ID: 25761839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal oxytocin and vasopressin manipulation alter social behavior during the juvenile period in Mongolian gerbils.
    Taylor JH; Cavanaugh J; French JA
    Dev Psychobiol; 2017 Jul; 59(5):653-657. PubMed ID: 28561891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxytocin-induced analgesia and scratching are mediated by the vasopressin-1A receptor in the mouse.
    Schorscher-Petcu A; Sotocinal S; Ciura S; Dupré A; Ritchie J; Sorge RE; Crawley JN; Hu SB; Nishimori K; Young LJ; Tribollet E; Quirion R; Mogil JS
    J Neurosci; 2010 Jun; 30(24):8274-84. PubMed ID: 20554879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of oxytocin receptors, but not arginine-vasopressin V1a receptors, in the ventral tegmental area of male Syrian hamsters is essential for the reward-like properties of social interactions.
    Song Z; Borland JM; Larkin TE; O'Malley M; Albers HE
    Psychoneuroendocrinology; 2016 Dec; 74():164-172. PubMed ID: 27632574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional c-Fos expression induced by peripheral oxytocin administration is prevented by the vasopressin 1A receptor antagonist SR49059.
    Hicks C; Ramos L; Dampney B; Baracz SJ; McGregor IS; Hunt GE
    Brain Res Bull; 2016 Oct; 127():208-218. PubMed ID: 27725169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxytocin induces social communication by activating arginine-vasopressin V1a receptors and not oxytocin receptors.
    Song Z; McCann KE; McNeill JK; Larkin TE; Huhman KL; Albers HE
    Psychoneuroendocrinology; 2014 Dec; 50():14-9. PubMed ID: 25173438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective blockade of oxytocin and vasopressin V(1a) receptors in anaesthetised rats: evidence that activation of oxytocin receptors rather than V(1a) receptors increases sodium excretion.
    Shirley DG; Walter MF; Keeler BD; Waters NJ; Walter SJ
    Nephron Physiol; 2011; 117(3):p21-6. PubMed ID: 21071981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential use of oxytocin and vasopressin V1a antagonists in the treatment of preterm labour and primary dysmenorrhoea.
    Akerlund M; Melin P; Maggi M
    Adv Exp Med Biol; 1995; 395():595-600. PubMed ID: 8714023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxytocin and vasopressin in the medial amygdala differentially modulate approach and avoidance behavior toward illness-related social odor.
    Arakawa H; Arakawa K; Deak T
    Neuroscience; 2010 Dec; 171(4):1141-51. PubMed ID: 20933576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.